ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.
Market
Genetically defined neurodegenerative diseases
Location
South San Francisco,
California,
USA
Coinvestors
Avidity Partners, CAM Capital, Johnson & Johnson Innovation, New Leaf Venture Partners, Novartis Venture Funds, Novo Holdings, OrbiMed Advisors, Osage University Partners, Rock Springs Capital, Sphera Funds Management, Surveyor Capital, Wellington Management Company